Can, Ö. Et Al. 2014. GADD45γ methylation is more common in benign prostatic hyperplasia than in prostate cancer. Gene Therapy and Molecular Biology , vol.16, no.1 , 44-54.

Can, Ö., Caner, V., Turk, N. S., Tuncay, O. L., ESKICORAPCI, S. Y., Tepeli, E., ... Cetin, O.(2014). GADD45γ methylation is more common in benign prostatic hyperplasia than in prostate cancer. Gene Therapy and Molecular Biology , vol.16, no.1, 44-54.

Can, Özge Et Al. "GADD45γ methylation is more common in benign prostatic hyperplasia than in prostate cancer," Gene Therapy and Molecular Biology , vol.16, no.1, 44-54, 2014

Can, Özge Et Al. "GADD45γ methylation is more common in benign prostatic hyperplasia than in prostate cancer." Gene Therapy and Molecular Biology , vol.16, no.1, pp.44-54, 2014

Can, Ö. Et Al. (2014) . "GADD45γ methylation is more common in benign prostatic hyperplasia than in prostate cancer." Gene Therapy and Molecular Biology , vol.16, no.1, pp.44-54.

@article{article, author={Özge Can Et Al. }, title={GADD45γ methylation is more common in benign prostatic hyperplasia than in prostate cancer}, journal={Gene Therapy and Molecular Biology}, year=2014, pages={44-54} }